Oxford (OXFD) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Oxford Immunotec Reports Third Quarter 2015 Financial Results
November 3, 2015 7:00 AM ESTThird quarter revenue of $17.9 million increased 41% on a constant currency basis compared to prior year periodGross margin improved by 390 basis points compared to prior year periodTwo seasoned diagnostics executives appointed to the Board of Directors
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLCÂ (Nasdaq: OXFD), a global, commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions, today announced third quarter 2015 financial results.
"We are very pleased with our third quarter financial and... More
